[go: up one dir, main page]

DK2110666T3 - Hidtil ukendt fremgangsmåde til at detektere og analysere proteininteraktioner in vivo - Google Patents

Hidtil ukendt fremgangsmåde til at detektere og analysere proteininteraktioner in vivo

Info

Publication number
DK2110666T3
DK2110666T3 DK09165808.8T DK09165808T DK2110666T3 DK 2110666 T3 DK2110666 T3 DK 2110666T3 DK 09165808 T DK09165808 T DK 09165808T DK 2110666 T3 DK2110666 T3 DK 2110666T3
Authority
DK
Denmark
Prior art keywords
protein
cell
interaction
protein interactions
detection
Prior art date
Application number
DK09165808.8T
Other languages
English (en)
Inventor
Sylvia Gruenewald
Moritz Rossner
Rico Laage
Klaus-Armin Nave
Original Assignee
Sygnis Bioscience Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sygnis Bioscience Gmbh & Co Kg filed Critical Sygnis Bioscience Gmbh & Co Kg
Application granted granted Critical
Publication of DK2110666T3 publication Critical patent/DK2110666T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00Methods of screening libraries
    • C40B30/04Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1055Protein x Protein interaction, e.g. two hybrid selection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK09165808.8T 2002-03-13 2003-03-13 Hidtil ukendt fremgangsmåde til at detektere og analysere proteininteraktioner in vivo DK2110666T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10211063A DE10211063A1 (de) 2002-03-13 2002-03-13 Neue Verfahren zur Detektion und Analyse von Protein-Interaktionen in vivo
EP03743880A EP1483576B1 (de) 2002-03-13 2003-03-13 Neue verfahren zur detektion und analyse von protein-interaktionen in vivo

Publications (1)

Publication Number Publication Date
DK2110666T3 true DK2110666T3 (da) 2013-04-08

Family

ID=27797747

Family Applications (2)

Application Number Title Priority Date Filing Date
DK09165808.8T DK2110666T3 (da) 2002-03-13 2003-03-13 Hidtil ukendt fremgangsmåde til at detektere og analysere proteininteraktioner in vivo
DK03743880.1T DK1483576T3 (da) 2002-03-13 2003-03-13 Hidtil ukendt fremgangsmåde til detektion og analysering af proteininteraktioner in vivo

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK03743880.1T DK1483576T3 (da) 2002-03-13 2003-03-13 Hidtil ukendt fremgangsmåde til detektion og analysering af proteininteraktioner in vivo

Country Status (7)

Country Link
US (2) US7585635B2 (da)
EP (2) EP2110666B1 (da)
AT (1) ATE483971T1 (da)
AU (1) AU2003215660A1 (da)
DE (2) DE10211063A1 (da)
DK (2) DK2110666T3 (da)
WO (1) WO2003076932A2 (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7695723B2 (en) 2002-12-31 2010-04-13 Sygnis Bioscience Gmbh & Co. Kg Methods of treating neurological conditions with hematopoietic growth factors
US7785601B2 (en) 2002-12-31 2010-08-31 Sygnis Bioscience Gmbh & Co. Kg Methods of treating neurological conditions with hematopoietic growth factors
US20070224615A1 (en) * 2003-07-09 2007-09-27 Invitrogen Corporation Methods for assaying protein-protein interactions
CA2531698A1 (en) * 2003-07-09 2005-01-27 Sentigen Biosciences, Inc. Method for assaying protein-protein interaction
DE10343375A1 (de) * 2003-09-17 2005-04-28 Axaron Bioscience Ag Verfahren zur Detektion und Analyse von Protein-Protein-Interaktionen
WO2006002100A2 (en) * 2004-06-21 2006-01-05 Progenra Inc. Diagnostic and screening methods and kits associated with proteolytic activity
EP1893627A4 (en) * 2005-05-27 2009-11-11 Sentigen Biosciences Inc MULTIPLEXARRAY SUITABLE FOR THE INVESTIGATION OF PROTEIN-PROTEIN INTERACTIONS
US20070026012A1 (en) * 2005-08-01 2007-02-01 Cornell Research Foundation, Inc. Compositions and methods for monitoring and altering protein folding and solubility
US9150850B2 (en) * 2005-08-22 2015-10-06 Cornell Research Foundation, Inc. Compositions and methods for analyzing protein interactions
WO2007030937A2 (en) * 2005-09-16 2007-03-22 Institut De Recherches Cliniques De Montreal/I.R.C.M. Screening proteinase modulators using a chimeric protein and ski-i proprotein convertase substrates and inhibitors
US20100009348A1 (en) * 2005-09-28 2010-01-14 Attagene, Inc. Methods and Constructs for Analyzing Biological Activities of Biological Specimens and Determining States of Organism
WO2007127538A1 (en) * 2006-03-16 2007-11-08 Invitrogen Corporation Methods for assaying protein-protein interaction
WO2008089132A2 (en) * 2007-01-12 2008-07-24 Cornell Research Foundation, Inc. Genetic selection for protein folding and solubility in the bacterial periplasm
EP2344676A1 (en) * 2008-09-25 2011-07-20 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Combinatorial synthesis and use of libraries of short expressed nucleic acid sequences for the analysis of cellular events
US9169312B2 (en) * 2010-09-21 2015-10-27 San Diego State University Research Foundation Compositions and methods for identifying enzyme and transport protein inhibitors
WO2013022739A1 (en) * 2011-08-05 2013-02-14 Leonard Joshua N Modular extracellular sensor architecture for cell-based biosensors
US10655124B2 (en) * 2014-10-20 2020-05-19 The Scripps Research Institute Proximity based methods for selection of binding partners
WO2016186575A1 (en) * 2015-05-15 2016-11-24 Agency For Science, Technology And Research Native protein purification technology
NZ743983A (en) 2016-01-11 2025-08-29 Univ Leland Stanford Junior Chimeric proteins and methods of regulating gene expression
WO2017123556A1 (en) 2016-01-11 2017-07-20 The Board Of Trustees Of The Leland Stanford Junior University Chimeric proteins and methods of immunotherapy
EP3497231B1 (en) 2016-08-08 2023-10-04 Technology Innovation Momentum Fund (Israel) Limited Partnership Bacterial systems for analyzing ubiquitylated polypeptides
US12454689B2 (en) 2017-03-23 2025-10-28 Northwestern University Integration of mesa receptors and promotors to implement customized cellular function
JP7315478B2 (ja) * 2017-06-08 2023-07-26 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド エピトープを特定するための方法および組成物
EP3665283A4 (en) 2017-08-08 2021-04-21 Technology Innovation Momentum Fund (Israel) Limited Partnership CHLORAMPHENICOL RESISTANT TRUNCATED PROTEIN AND ITS USES
US11649509B2 (en) 2017-11-16 2023-05-16 The Johns Hopkins University Anastasis biosensor caspase tracker
BR112020021826A2 (pt) * 2018-04-26 2021-02-23 Paean Biotechnology Inc. mitocôndrias modificadas e uso das mesmas
WO2020026979A1 (ja) * 2018-07-31 2020-02-06 国立大学法人東京大学 膜タンパク質活性測定法
EP3891279A1 (en) * 2018-12-07 2021-10-13 Octant, Inc. Systems for protein-protein interaction screening
US20230152329A1 (en) * 2020-03-06 2023-05-18 Arizona Board Of Regents On Behalf Of The University Of Arizona Novel split-luciferase enzymes and applications thereof
WO2022094463A1 (en) * 2020-11-02 2022-05-05 Regents Of The University Of Minnesota Live cell assay for protease inhibition
WO2022183024A2 (en) * 2021-02-26 2022-09-01 Cornell University Cell-based assay for protease inhibitors
SE547227C2 (en) * 2023-10-27 2025-06-10 Markus Schmid Identification of (poly)peptide-(poly)peptide interactions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1293460C (en) 1985-10-07 1991-12-24 Brian Lee Sauer Site-specific recombination of dna in yeast
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
WO1993015191A1 (en) * 1992-01-24 1993-08-05 Life Technologies, Inc. Modulation of enzyme activities in the in vivo cloning of dna
WO1993021324A1 (en) * 1992-04-21 1993-10-28 Institut Pasteur Recombinant mutants for inducing specific immune responses
US5935580A (en) * 1992-04-21 1999-08-10 Institut Pasteur Recombinant mutants for inducing specific immune responses
US5585245A (en) 1994-04-22 1996-12-17 California Institute Of Technology Ubiquitin-based split protein sensor
US5695941A (en) * 1994-06-22 1997-12-09 The General Hospital Corporation Interaction trap systems for analysis of protein networks
FR2734567B1 (fr) * 1995-05-26 1997-08-08 Commissariat Energie Atomique Proteines chimeriques activant la transcription par la polymerase iii, leur utilisation pour la detection et l'analyse des interactions entre proteines, et genes codant pour lesdites proteines
DE19650714A1 (de) * 1996-12-06 1998-06-10 Melchner Harald Von Prof Dr Genfallen-Konstrukt zur Identifizierung und Isolierung von Genen
JP4060372B2 (ja) * 1996-12-11 2008-03-12 ブリストル−マイヤーズ・スクイブ・カンパニー 原核生物の二ハイブリッド系
US6294330B1 (en) 1997-01-31 2001-09-25 Odyssey Pharmaceuticals Inc. Protein fragment complementation assays for the detection of biological or drug interactions
GB9718591D0 (en) 1997-09-03 1997-11-05 Zeneca Ltd Methods
US5885779A (en) * 1997-09-09 1999-03-23 University Of British Columbia Repressed trans-activator system for characterization of protein-protein interactions
US6828099B2 (en) 1998-02-02 2004-12-07 Odyssey Thera Inc. Protein fragment complementation assay (PCA) for the detection of protein-protein, protein-small molecule and protein nucleic acid interactions based on the E. coli TEM-1 β-Lactamase
US6303627B1 (en) * 1998-06-19 2001-10-16 Eli Lilly And Company Inhibitors of serotonin reuptake
WO2001066787A1 (en) * 2000-03-08 2001-09-13 Tvw Telethon Institute For Child Health Research Improved reverse n-hybrid screening method
AUPQ776100A0 (en) * 2000-05-26 2000-06-15 Australian National University, The Synthetic molecules and uses therefor

Also Published As

Publication number Publication date
WO2003076932A2 (de) 2003-09-18
DK1483576T3 (da) 2011-01-31
AU2003215660A1 (en) 2003-09-22
EP1483576A2 (de) 2004-12-08
WO2003076932A3 (de) 2004-09-02
AU2003215660A8 (en) 2003-09-22
US8349619B2 (en) 2013-01-08
EP1483576B1 (de) 2010-10-06
EP2110666B1 (de) 2012-12-26
DE50313154D1 (de) 2010-11-18
ATE483971T1 (de) 2010-10-15
DE10211063A1 (de) 2003-10-09
US20090298089A1 (en) 2009-12-03
US20050084864A1 (en) 2005-04-21
US7585635B2 (en) 2009-09-08
EP2110666A1 (de) 2009-10-21

Similar Documents

Publication Publication Date Title
DK2110666T3 (da) Hidtil ukendt fremgangsmåde til at detektere og analysere proteininteraktioner in vivo
DE60326482D1 (de) Testverfahren für zustandsabhängige calciumkanal-agonisten/-antagonisten
DE60317422D1 (de) Mediator-stabilisierende Verbindung und Methoden zur Verwendung zur Detektion elektrochemischer Analyte
DK1032705T3 (da) Probearrays og fremgangsmåder til at benytte probearrays til at skelne mellem DNA
RU2003106972A (ru) Способ оценки качества тестирующей полоски (варианты), устройство и считываемый компьютером носитель
ATE498011T1 (de) Modifizierte embryonale stammzellen und embryonales stammzellspezifisches gen
ATE431427T1 (de) Verbessertes verfahren zum nachweis von atp
ATE278186T1 (de) Elektrochemischer sensor zur bestimmung der blutgerinnung, ein entsprechendes blutgerinnungsmesssystem sowie ein verfahren zur bestimmung der blutgerinnung
ATE426041T1 (de) Zirkulare sonden amplifizierung (cpa) von zirkularisierten nucleinsaure-molekulen
CY1108630T1 (el) Εξεταση βιοισοδυναμιας δια συνθεσεις οι οποιες περιεχουν σιδηρο
DE602005016800D1 (de) Hif-prolylhydroxylase-aktivitätstest
ATE384139T1 (de) Multi-test-analyse von echzeit- nukleinsäureamplifikationen
DK1400589T3 (da) Fremgangsmåde til påvisning af prokaryotisk DNA
ATE432363T1 (de) Verfahren zum testen von weizen
ATE383418T1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
DK1606622T3 (da) Testfremgangsmåde til bestemmelse af den intracellulære koncentration af cykliske nukleotider
DE50300480D1 (de) Verfahren zur Testung des hormonellen Effekts von Substanzen
DE60114443D1 (de) Verfahren zur identifizierung von listeria-monozytogenen und kulturmedium
DE60327776D1 (de) Sonden zum nachweis von tumorzellen
DK1416275T3 (da) Kontrolanordning til hurtigtest
ATE432945T1 (de) Die aktivität von ccrl2 modulierende mittel und verfahren zu deren anwendung
Chappell Reply to “Letter to the editor: Angiotensin quantification by mass spectrometry”
ATE403863T1 (de) Verfahren zum nachweis von intrazellulären atp und/oder genexpression
ATE313800T1 (de) Verfahren zur analyse der funktionellen aktivierung von leukocyten, plättchen und anderen zellen
NO20061858L (no) Ledersekvenser for anvendelse ved produksjon av proteiner